Developing New Medicines Through Artificial Intelligence
On September 30, 2012, a computer program named “AlexNet” won an international competition and ushered in a new age of artificial intelligence (AI)....
On September 30, 2012, a computer program named “AlexNet” won an international competition and ushered in a new age of artificial intelligence (AI)....
While many biopharmaceutical companies are built to fulfil a need, Resilience was built to serve innovation. Founded during the COVID-19 pandemic in...
Manufacturing capabilities need innovation proportional to those in therapeutics discovery. Choosing a CDMO partner with the technologies and...
Are you an innovative company looking for a dependable CDMO partner for your large molecule projects? You have come to the right place.
by Adam Mendez, Alissa Gordon, and Lee Tessler Originally published on AWS | 27 NOV 2023 We would like to acknowledge the valuable contributions of...
Are you an innovator company looking for a reliable and innovative partner? You have come to the right place.
Resilience and Pluristyx have entered a strategic collaboration to accelerate and simplify the transition of promising iPSC-derived therapies from...
Event Overview: Join us for an informative webcast with industry experts as they address critical challenges in viral vector manufacturing that...